Crennen Lyndsey Elizabeth sold $40K of MLAB
Crennen Lyndsey Elizabeth (CAO) sold 442 shares of MESA LABORATORIES INC /CO/ (MLAB) at $89.50 on 2026-06-22.
How this was made
The 30-second read
Why it matters
The newest fact is the CAO’s open-market sale details (442 shares at $89.5020; ~$39.6K total) and post-transaction holdings (2,020 shares).
Market read
Traders may note the insider sale as a small sentiment datapoint, but it does not introduce new fundamentals.
What to watch
Insider sales are common and often not predictive without accompanying changes in guidance, large-scale selling, or repeated transactions over time.
Background
The article is an SEC Form 4 insider transaction disclosure for MESA Laboratories Inc (MLAB).
Ticker impact
Form 4 shows CAO Lyndsey Elizabeth Crennen sold 442 shares of MESA Laboratories at $89.5020 on 2026-06-22, totaling ~$39.6K.
Low likelihood of a sustained price move; any reaction is likely muted and short-lived.
The filing is a disclosed insider transaction with modest dollar value and no stated 10b5-1 plan, but it does not include new company fundamentals or guidance.
Market effects
Minimal; this is company-specific insider activity with no sector-wide catalyst.
None indicated.
None indicated.
Counterpoint
The sale could be for diversification, taxes, or pre-planned personal liquidity needs; absence of a 10b5-1 plan doesn’t necessarily imply bearish expectations.
Key entities
- issuerMLAB
MESA Laboratories Inc /CO/; subject of the Form 4 insider transaction.
- insiderLyndsey Elizabeth Crennen
CAO of MESA Laboratories; reported open-market sale of 442 shares.
